Cancer

Oncology & Cancer

Recommendations issued for prevention of ovarian cancer

(HealthDay)—Recommendations for prevention of ovarian cancer include oral contraceptive use and tubal sterilization, as well as genetic counseling and testing for women from high-risk families, according to a report from ...

Oncology & Cancer

Metformin use associated with less CRC risk in US population

(HealthDay)—For patients with diabetes in the United States, metformin use is associated with reduced risk of developing colorectal cancer (CRC), according to a study published in the April 1 issue of Cancer.

Oncology & Cancer

Lycopene inversely linked to renal cell carcinoma risk

(HealthDay)—For postmenopausal women, lycopene intake seems to be inversely associated with the risk of renal cell carcinoma (RCC), according to a study published in the Feb. 15 issue of Cancer.

Oncology & Cancer

Marriage may be a cancer fighter

(HealthDay)—A wedding band may be powerful medicine against cancer, a new study suggests.

Oncology & Cancer

Breast cancer patients weigh in on addressing financial burdens

A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial ...

Oncology & Cancer

Research aims to reduce health care disparities

The lesbian, gay, bisexual, transgender/transsexual, queer/questioning and intersex (LGBTQI) population has been largely understudied by the medical community. Researchers at Moffitt Cancer Center found that the LGBTQI community ...

Oncology & Cancer

Risk factors ID'd for diffuse large B-cell lymphoma mortality

(HealthDay)—Age, stage, and Charlson Comorbidity Index (CCI) are risk factors for diffuse large B-cell lymphoma (DLBCL)-specific death in older patients, according to a study published online Feb. 1 in Cancer.

Oncology & Cancer

Patients' HIV status should not impact their cancer care

New articles published in Cancer, a peer-reviewed journal of the American Cancer Society, note that there is no medical justification to deny optimal cancer therapy to individuals with HIV.

Oncology & Cancer

No link found between vitamin D level and fatal prostate cancer

(HealthDay)—Neither circulating 25-hydroxyvitamin D (25[OH]D) levels nor common variations in vitamin D pathway genes appear to be associated with risk of fatal prostate cancer, according to research published online March ...

page 6 from 47